NCT03201978 A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects Status WITHDRAWN Phase PHASE1
NCT03201211 A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults Status COMPLETED Phase PHASE1
NCT03197883 Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure Status COMPLETED Phase NA
NCT03192371 A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children Status WITHDRAWN Phase PHASE4
NCT03191383 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers Status WITHDRAWN Phase PHASE2
NCT03189589 Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03188458 Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia Status TERMINATED Phase PHASE4
NCT03184987 A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma Status COMPLETED Phase PHASE3
NCT03183518 To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants Status COMPLETED Phase NA
NCT03183492 Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel Status WITHDRAWN Phase PHASE4
NCT03180645 Proof of Concept Anti-ageing Clinical Study in Healthy Subjects Status COMPLETED Phase NA
NCT03177603 A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE2
NCT03175562 To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants Status COMPLETED Phase NA
NCT03172364 To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin Status COMPLETED Phase NA
NCT03170999 Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT03170232 A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) Status TERMINATED Phase PHASE2
NCT03168438 Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma Status TERMINATED Phase PHASE1